4//SEC Filing
Afdhal Nezam H. 4
Accession 0001209191-18-003915
CIK 0001566373other
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 4:03 PM ET
Size
5.5 KB
Accession
0001209191-18-003915
Insider Transaction Report
Form 4
Afdhal Nezam H.
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-01-16+50,000→ 50,000 totalExercise: $12.10Exp: 2028-01-16→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This option was granted on January 16, 2018, with 25% of the shares subject to the option vesting on January 16, 2019 and the remaining 75% of the shares subject to the option vesting in 36 equal monthly installments thereafter.
Documents
Issuer
Spring Bank Pharmaceuticals, Inc.
CIK 0001566373
Entity typeother
Related Parties
1- filerCIK 0001664569
Filing Metadata
- Form type
- 4
- Filed
- Jan 16, 7:00 PM ET
- Accepted
- Jan 17, 4:03 PM ET
- Size
- 5.5 KB